February 11, 2009 -- China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, announced today that the company has initiated clinical trials for the generic version of the leading hypertension drug Candesartan.
The details can be read here.
No comments:
Post a Comment